The Appraisal Arbitrage Endgame: Why Silver Lake’s Lawsuit Against Carl Icahn Threatens to Close Delaware’s Most Controversial Loophole

The Offensive Strike on Section 262

For nearly two decades, Delaware corporate law has tolerated a cottage industry built on a legal fiction. That fiction—that an investor who buys stock in a target company after a merger is announced can credibly claim to be a "dissenting" shareholder forced out against their will—birthed the highly lucrative practice of appraisal arbitrage. But on September 21, 2026, private equity behemoth Silver Lake launched a direct, existential attack on this practice. By suing Carl Icahn and a syndicate of hedge funds in the Delaware Court of Chancery, Silver Lake is seeking a declaratory judgment that post-announcement buyers cannot pursue appraisal rights in its buyout of Endeavor Group Holdings.

This is not just another skirmish over deal price. It is a calculated, well-timed assault on a foundational precedent that has frustrated dealmakers since 2005. If Silver Lake succeeds, it will effectively kill appraisal arbitrage in Delaware, restoring the statutory appraisal remedy to its original, intended beneficiaries: long-term shareholders squeezed out in a change of control.

The Ghost of Transkaryotic

To understand why Silver Lake’s lawsuit is a seismic event for M&A litigators, you have to look at the flaw in the plumbing of modern securities trading and how Delaware courts previously chose to handle it. Under Section 262 of the Delaware General Corporation Law (DGCL), a stockholder who continuously holds shares through the effective date of a merger and who neither votes in favor of the deal nor consents to it in writing is entitled to a judicial appraisal of their shares' "fair value." See 8 Del. C. § 262(a).

The problem arose in In re Appraisal of Transkaryotic Therapies, Inc., 884 A.2d 1155 (Del. Ch. 2005). Because the vast majority of publicly traded shares are held in "street name" through the central depository Cede & Co., shares are entirely fungible. When an activist hedge fund buys shares after a deal is announced, it is virtually impossible to trace whether the specific shares they purchased were voted "for" or "against" the merger by the previous owner. In Transkaryotic, the Chancery Court ruled that as long as Cede & Co. (the record holder) had enough unvoted shares in the aggregate to cover the appraisal demand, the beneficial owner had standing to seek appraisal—even if they bought the stock just days before the deal closed.

The Transkaryotic decision effectively decoupled the statutory purpose of appraisal from its mechanical execution. It transformed Section 262 from a shield for aggrieved long-term investors into a tradable litigation ticket for hedge funds looking to squeeze a premium out of acquirers.

Why Silver Lake is Striking Now

Silver Lake’s decision to play offense against Icahn is a masterclass in reading the room. Over the past decade, the Delaware Supreme Court has systematically chipped away at the economic incentives of appraisal arbitrage, most notably in Dell, Inc. v. Magnetar Glob. Event Driven Master Fund Ltd., 177 A.3d 1 (Del. 2017), and DFC Glob. Corp. v. Muirfield Value Partners, L.P., 172 A.3d 346 (Del. 2017). In those landmark rulings, the state’s high court strongly endorsed the unaffected deal price as the best indicator of "fair value" in an arm's-length transaction, largely eliminating the massive judicial bumps arbitrageurs used to secure.

However, while Dell and DFC Global reduced the ROI of appraisal litigation, they did not touch the underlying standing issue. Hedge funds like Icahn’s can still buy post-announcement shares and wield the threat of lengthy, expensive discovery and statutory interest rates to extract settlements from buyers who just want deal certainty. Silver Lake is arguing that enough is enough. By seeking a ruling that post-announcement buyers inherently lack standing, Silver Lake is asking the Chancery Court to recognize that buying into a known deal price negates the very concept of "dissenting" from it.

The Practical Impact for Deal Lawyers

For practicing M&A attorneys and corporate litigators, the Endeavor litigation is the most important appraisal case on the docket. Here is what changes if Silver Lake prevails:

1. The End of the Appraisal Arbitrage Asset Class: If Chancery (and inevitably, the Delaware Supreme Court) overturns or heavily distinguishes Transkaryotic, hedge funds will no longer be able to deploy capital post-announcement solely to hijack the appraisal statute. The secondary market for merger litigation claims will collapse.

2. Shifts in Merger Agreement Drafting: Currently, buyers routinely negotiate "appraisal out" clauses—conditions allowing the buyer to walk away if a certain percentage of shares demand appraisal. If post-announcement buyers are barred from the appraisal pool, the threat of crossing these thresholds drops dramatically. Acquirers will have far more deal certainty between signing and closing.

3. The Traceability Burden: A ruling for Silver Lake would likely force the market to solve the traceability problem. If the courts require proof that the specific shares purchased were not voted in favor of the deal, beneficial owners and brokers will have to develop technological mechanisms to track the voting history of individual share lots—a massive compliance shift for the clearinghouses.

The Verdict

Silver Lake is entirely correct on the merits. The legislative intent behind Section 262 was never to create a risk-free yield strategy for billionaires who buy stock with full knowledge of a pending merger. While the mechanical realities of Cede & Co. made Transkaryotic a pragmatic ruling in 2005, the subsequent explosion of appraisal arbitrage demands a course correction.

The Delaware courts have spent the last ten years trying to fix the appraisal problem by tweaking the valuation methodologies. It is time they finally fix the standing problem. Litigators representing target boards and acquirers should watch the Endeavor docket closely; we are likely witnessing the beginning of the end for Delaware's most notorious loophole.